EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Prostate cancer and bone: clinical presentation and molecular mechanisms

Kristina V Wells iD, Margaret L Krackeler iD, Maitreyee K Jathal, Mamta Parikh, Paramita M Ghosh iD, J Kent Leach iD, Damian C Genetos iD

Endocrine-Related Cancer · 2023

DOI: 10.1530/erc-22-0360 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine-Related Cancer, 2023. Verfasst von Kristina V Wells und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Physiology, and Cell Biology, University of California Davis School of Veterinary Medicine, Davis, California, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Bone Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 236 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NCI NIH HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) is an increasingly prevalent health problem in the developed world. Effective treatment options exist for localized PCa, but metastatic PCa has fewer treatment options and shorter patient survival. PCa and bone health are strongly entwined, as PCa commonly metastasizes to the skeleton. Since androgen receptor signaling drives PCa growth, androgen-deprivation therapy whose sequelae reduce bone strength constitutes the foundation of advanced PCa treatment. The homeostatic process of bone remodeling – produced by concerted actions of bone-building osteoblasts, bone-resorbing osteoclasts, and regulatory osteocytes — may also be subverted by PCa to promote metastatic growth. Mechanisms driving skeletal development and homeostasis, such as regional hypoxia or matrix-embedded growth factors, may be subjugated by bone metastatic PCa. In this way, the biology that sustains bone is integrated into adaptive mechanisms for the growth and survival of PCa in bone. Skeletally metastatic PCa is difficult to investigate due to the entwined nature of bone biology and cancer biology. Herein, we survey PCa from origin, presentation, and clinical treatment to bone composition and structure and molecular mediators of PCa metastasis to bone. Our intent is to quickly yet effectively reduce barriers to team science across multiple disciplines that focuses on PCa and metastatic bone disease. We also introduce concepts of tissue engineering as a novel perspective to model, capture, and study complex cancer-microenvironment interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBone NeoplasmsMaleHumansAndrogen AntagonistsBone and BonesTreatment OutcomeTumor Microenvironment

Stichwörter der Autor:innen

androgen receptorbonehypoxiametastasisprostate cancertissue engineering

Substanzen

Androgen Antagonists

Autor:innen und Institutionen

  • Department of Anatomy, Physiology, and Cell Biology, University of California Davis School of Veterinary Medicine, Davis, California, USA.
  • Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, California, USA.
  • Department of Medical Microbiology and Immunology, University of California Davis, Davis, California, USA.
  • Veterans Affairs-Northern California Health System, Mather, California, USA.
  • Division of Hematology and Oncology, School of Medicine, University of California Davis, Sacramento, California, USA.
  • Department of Urologic Surgery, School of Medicine, University of California Davis, Sacramento, California, USA.

ORCID-Profile: Kristina V Wells, Margaret L Krackeler, Paramita M Ghosh, J Kent Leach, Damian C Genetos

Förderung

  • NIAMS NIH HHS
  • NCI NIH HHS
  • BLRD VA

Zitieren

APA

Wells, K. V., Krackeler, M. L., Jathal, M. K., Parikh, M., Ghosh, P. M., Leach, J. K., & Genetos, D. C. (2023). Prostate cancer and bone: clinical presentation and molecular mechanisms. Endocrine-Related Cancer. https://doi.org/10.1530/erc-22-0360

Vancouver

Wells KV, Krackeler ML, Jathal MK, Parikh M, Ghosh PM, Leach JK, et al. Prostate cancer and bone: clinical presentation and molecular mechanisms. Endocrine-Related Cancer. 2023. doi:10.1530/erc-22-0360

BibTeX
@article{Wells2023,
  author = {Wells, Kristina V and Krackeler, Margaret L and Jathal, Maitreyee K and Parikh, Mamta and Ghosh, Paramita M and Leach, J Kent and Genetos, Damian C},
  title = {Prostate cancer and bone: clinical presentation and molecular mechanisms},
  journal = {Endocrine-Related Cancer},
  year = {2023},
  doi = {10.1530/erc-22-0360}
}
Kostenlos starten →